Conclusion
Marked symptomatic relief is provided by Cortisone therapy in ethmoidal polypi where the element of allergy predominates and infection is absent. Early small sized polyp cases benefit more.
Where there are no contra-indications for cortisone and patient is apprehensive about operative treatment, the use of cortisone is worth a trial.
Similar content being viewed by others
References
Dolowitz, D. A. and Doughety T. F.: ‘Nasal Polyposis’, A.M.A. Arch. Otolaryng. 74/2 171–177, 1961.
Klein Toulon, ’The effect of delta-hydrocortisone in a deforming nasal polyposis’, J. Franc. Oto. Rhino. Laryng. 7/3 333–340 1958.
Lecco, V., First results of the use of cortisone given by aerosol in the treatment of nasal polypi. ’Arch. Ital. Otol. 64/Suppl. 13: 200–212, 1953.
Lederer Francis, L. ‘The problem of nasal polyps’, Journal of Allergy 30:420, 1961.
Mc. Laren, W. R. ‘An evaluation of Triaminic and Hydrocortisone in treatment of nasal allergy, nasal polyposis and asthma.’ Annals Allergy 17/4: 546–556, 1959.
Myer, D. ‘Experiences in the treatment of the allergic nasal polyp by the intra-polyp injection of prednisolone.’ Laryngoscope, 68/1: 1–17, 1958.
Author information
Authors and Affiliations
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/BF03047506.
Rights and permissions
About this article
Cite this article
Kaker, P. Cortisone treatment of nasal polyps. Ind. J. Otol. 20, 119–120 (1968). https://doi.org/10.1007/BF03048289
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03048289